These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

628 related items for PubMed ID: 9367528

  • 21. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
    Dudley BF, Winston GW.
    Arch Biochem Biophys; 1995 Feb 01; 316(2):879-85. PubMed ID: 7532387
    [Abstract] [Full Text] [Related]

  • 22. Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells.
    Schlager JJ, Hoerl BJ, Riebow J, Scott DP, Gasdaska P, Scott RE, Powis G.
    Cancer Res; 1993 Mar 15; 53(6):1338-42. PubMed ID: 8443814
    [Abstract] [Full Text] [Related]

  • 23. Unexpected genetic and structural relationships of a long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase).
    Zhao Q, Yang XL, Holtzclaw WD, Talalay P.
    Proc Natl Acad Sci U S A; 1997 Mar 04; 94(5):1669-74. PubMed ID: 9050836
    [Abstract] [Full Text] [Related]

  • 24. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD, Murphy AM, Siegel D, Hargreaves RH, Butler J, Ross D.
    Mol Pharmacol; 1995 Sep 04; 48(3):499-504. PubMed ID: 7565631
    [Abstract] [Full Text] [Related]

  • 25. A likely molecular basis of the susceptibility of Giardia lamblia towards oxygen.
    Li L, Wang CC.
    Mol Microbiol; 2006 Jan 04; 59(1):202-11. PubMed ID: 16359329
    [Abstract] [Full Text] [Related]

  • 26. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis.
    Rauth AM, Goldberg Z, Misra V.
    Oncol Res; 1997 Jan 04; 9(6-7):339-49. PubMed ID: 9406240
    [Abstract] [Full Text] [Related]

  • 27. A two-domain structure for the two subunits of NAD(P)H:quinone acceptor oxidoreductase.
    Chen S, Deng PS, Bailey JM, Swiderek KM.
    Protein Sci; 1994 Jan 04; 3(1):51-7. PubMed ID: 7511454
    [Abstract] [Full Text] [Related]

  • 28. NRH:quinone oxidoreductase2 (NQO2).
    Long DJ, Jaiswal AK.
    Chem Biol Interact; 2000 Dec 01; 129(1-2):99-112. PubMed ID: 11154737
    [Abstract] [Full Text] [Related]

  • 29. Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
    Jamieson D, Tung AT, Knox RJ, Boddy AV.
    Br J Cancer; 2006 Nov 06; 95(9):1229-33. PubMed ID: 17031400
    [Abstract] [Full Text] [Related]

  • 30. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin.
    Cavelier G, Amzel LM.
    Proteins; 2001 Jun 01; 43(4):420-32. PubMed ID: 11340659
    [Abstract] [Full Text] [Related]

  • 31. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
    Gibson NW, Hartley JA, Butler J, Siegel D, Ross D.
    Mol Pharmacol; 1992 Sep 01; 42(3):531-6. PubMed ID: 1406604
    [Abstract] [Full Text] [Related]

  • 32. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB, Cadenas E.
    Arch Biochem Biophys; 1997 Oct 15; 346(2):241-51. PubMed ID: 9343371
    [Abstract] [Full Text] [Related]

  • 33. Roles of DT diaphorase in the genotoxicity of nitroaromatic compounds in human and fish cell lines.
    Hasspieler BM, Haffner GD, Adeli K.
    J Toxicol Environ Health; 1997 Oct 10; 52(2):137-48. PubMed ID: 9310146
    [Abstract] [Full Text] [Related]

  • 34. NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Celli CM, Tran N, Knox R, Jaiswal AK.
    Biochem Pharmacol; 2006 Jul 28; 72(3):366-76. PubMed ID: 16765324
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the quinone reductase activity of the ferric reductase B protein from Paracoccus denitrificans.
    Sedlácek V, van Spanning RJ, Kucera I.
    Arch Biochem Biophys; 2009 Mar 01; 483(1):29-36. PubMed ID: 19138657
    [Abstract] [Full Text] [Related]

  • 36. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under hypoxia.
    Begleiter A, Robotham E, Leith MK.
    Mol Pharmacol; 1992 Apr 01; 41(4):677-82. PubMed ID: 1373799
    [Abstract] [Full Text] [Related]

  • 37. Cellular kinetics of induction by oltipraz and its keto derivative of detoxication enzymes in human colon adenocarcinoma cells.
    O'Dwyer PJ, Clayton M, Halbherr T, Myers CB, Yao Ks.
    Clin Cancer Res; 1997 May 01; 3(5):783-91. PubMed ID: 9815750
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase.
    Chen S, Liu XF.
    Mol Pharmacol; 1992 Sep 01; 42(3):545-48. PubMed ID: 1406605
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.